Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Chengdu Tianyin Pharma Completes Reverse Merger

publication date: Jan 18, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Chengdu Tianyin Pharmaceutical Co. Ltd. effected a reverse merger with VisCorp (OTCBB: VSCO) on January 16, and at the same time, the company announced that it had successfully raised $10.2 million in a private placement. Tianyin Pharmaceutical Co., Inc. will become the new name of the company. Chengdu Tianyin, which was founded in 1994, manufactures traditional China medicines and other pharmaceuticals. In fiscal 2007, which ended June 30, 2007, Chengdu Tianyin reported revenues of $20.4 million and net income of $4.2 million. More details...

Stock Symbol: (OTCBB: VSCO)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners